Quality of life in cancer patients with diabetes on immunotherapy
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how immunotherapy affects the quality of life of cancer patients who also have diabetes. It aims to understand their well-being during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid tumor cancer confirmed by biopsy.
- You are about to start immunotherapy (either alone or with another immunotherapy).
- You can read and understand Danish well enough to fill out questionnaires.
- You are willing and able to give informed consent and complete surveys about your health and well-being.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This study looks at the physical and emotional needs of people with advanced cancer who are receiving immunotherapy. It aims to understand how these needs affect quality of life.
This study looks at how body composition and emotional factors affect cancer patients receiving immune checkpoint inhibitors (ICIs). It may help understand how these factors relate to treatment outcomes.
This British Columbia study looks at how well different cancer treatments work in real life when doctors aren't sure which option is best. You and your doctor would choose a treatment, and researchers will track your results to help others.
This study looks at side effects from immunotherapy in people with solid or blood cancers. It may help doctors better manage these side effects in the future.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.